Timedora

Intramuscular Epinephrine for Suspected Anaphylaxis

A focused lesson on prompt intramuscular epinephrine for suspected anaphylaxis, including thigh administration, dosing and repeat treatment, and the safety distinction from intravenous use.

Act promptly and use the right route

Treat suspected anaphylaxis without delay

Anaphylaxis can rapidly cause airway swelling, bronchospasm, falling blood pressure, and shock. Give intramuscular (IM) epinephrine promptly when anaphylaxis is suspected; do not wait for diagnostic certainty or delay treatment to give antihistamines, corticosteroids, or other adjuncts. These medicines do not replace epinephrine as first-line treatment.

Epinephrine acts on several adrenergic receptors. Its α₁ effects constrict blood vessels, helping support blood pressure and reduce capillary leak and mucosal swelling. Its β₂ effects relax bronchial smooth muscle, helping relieve bronchospasm. These actions address immediate airway and circulatory threats.

Route, site, and dose

Give the injection in the mid-anterolateral thigh. A commonly used clinician dose is 0.01 mg/kg of the 1 mg/mL solution IM, up to 0.5 mg per dose. This is a general protocol, not a substitute for local age- and weight-based guidance. If a patient has a prescribed epinephrine , use that device promptly according to its instructions.

After treatment, reassess breathing and circulation. If serious breathing or circulation problems persist, repeat as directed by the applicable protocol; many emergency protocols advise reassessment and repeat dosing after about 5 minutes. Follow local guidance for dose and timing.

Keep IM and IV use distinct

The 1 mg/mL concentration is used for IM injection in standard anaphylaxis protocols. Do not confuse this with intravenous (IV) administration: an incorrectly dosed IV epinephrine bolus can cause severe hypertension, arrhythmias, or other harm. IV infusion is reserved for refractory reactions and requires experienced clinicians and continuous monitoring.